OM DENNE EPISODE

Engelsk
USA

UDSKRIFT 🔗

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Talking Points.

ANDRE EPISODE I DENNE PODCAST

How has the pharmacotherapy for STEMI changed over the past 46 years? Ginger Jiang and C. Michael Gibson discuss treating patients with zalunfiban at first medical contact.

The META-AF Trial

Amrish Deshmukh talks to C. Michael Gibson about the use of metformin as an adjunctive therapy to catheter ablation of AF.

The TUXEDO-2 Trial

Sripal Bangalore and C. Michael Gibson discuss whether ticagrelor is noninferior to prasugrel in patients with diabetes and multivessel CAD undergoing PCI.
Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke.
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra TCTMD, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.